Study on Heart Rate Variability in Cardiac Transplant Recipients With Exercise and After Exercise Training

Cardiac Transplant Disorder Clinical Trial

Official title:

Study on Heart Rate Variability in Cardiac Transplant Recipients With Exercise and After Exercise Training

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01760538
• Other study ID #: 1913
• Secondary ID: NSC 90-2314-B-00
• Status: Completed
• Phase: N/A
• First received: January 2, 2013
• Last updated: January 3, 2013
• Start date: August 2001
• Est. completion date: September 2003

Study information

• Verified date: November 2012
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Interventional

Clinical Trial Summary

The purpose of the study was to investigate the changes on heart rate variability, exercise capacity, activities of daily living, and quality of life after aerobic exercise training in cardiac transplant recipients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: September 2003
• Est. primary completion date: September 2003
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 20 Years to 70 Years

Eligibility

Inclusion Criteria:

• Heart transplant recipients with stable post operation condition

• Age between 20-70 years

• No acute or severe chronic rejection

Exclusion Criteria:

• Any condition that might affect exercise performance

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Cardiac Transplant Disorder

Intervention

Behavioral:
• Exercise training
exercise training
• usual care
received usual medical care after heart transplantation

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Heart rate variability	R-R interval difference	8 weeks	No
Secondary	Exercise capacity	oxygen consumption	8 weeks	No
Secondary	Quality of life	This outcome measures how good life the patients have	8 weeks	No